Current practice managements regarding thromboembolic prophylaxis within the pediatric sarcoma patient population

Lauren Crocco, Richard Gorlick, David S. Geller

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

OBJECTIVE: Children with cancer are approximately 600 times more likely to develop thromboses than the general pediatric population. Current management strategies for children have been extrapolated from adult studies and prophylaxis guidelines remain controversial. The purpose of this study is to survey the current thromboembolic prophylaxis practice methods of physicians treating pediatric sarcoma patients. METHODS: Physicians involved in the care of sarcoma patients were surveyed using a 5-question survey designed to evaluate current clinical practices. RESULTS: Of 107 responding physicians, 67 identified themselves as involved in the treatment of pediatric sarcoma patients. The providers most likely to use any form of deep vein thrombosis prophylaxis were orthopedic surgeons (60%), followed by general surgeons (45%), pediatric oncologists (30%), and medical oncologists (25%). Of the providers polled, 48% use mechanical forms, 20% use chemical forms, and 31% use a combination. CONCLUSIONS: Currently, there is a lack of consensus regarding thromboembolic prophylaxis for pediatric sarcoma patients.

Original languageEnglish (US)
Pages (from-to)28-31
Number of pages4
JournalJournal of Pediatric Hematology/Oncology
Volume35
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Practice Management
Sarcoma
Pediatrics
Population
Physicians
Venous Thrombosis
Patient Care
Thrombosis
Guidelines
Neoplasms
Surveys and Questionnaires
Oncologists

Keywords

  • sarcoma
  • thromboembolic disease
  • thromboembolic prophylaxis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Current practice managements regarding thromboembolic prophylaxis within the pediatric sarcoma patient population. / Crocco, Lauren; Gorlick, Richard; Geller, David S.

In: Journal of Pediatric Hematology/Oncology, Vol. 35, No. 1, 01.2013, p. 28-31.

Research output: Contribution to journalArticle

@article{9e7bcdffde2d4cf8bb74d888de66ebdc,
title = "Current practice managements regarding thromboembolic prophylaxis within the pediatric sarcoma patient population",
abstract = "OBJECTIVE: Children with cancer are approximately 600 times more likely to develop thromboses than the general pediatric population. Current management strategies for children have been extrapolated from adult studies and prophylaxis guidelines remain controversial. The purpose of this study is to survey the current thromboembolic prophylaxis practice methods of physicians treating pediatric sarcoma patients. METHODS: Physicians involved in the care of sarcoma patients were surveyed using a 5-question survey designed to evaluate current clinical practices. RESULTS: Of 107 responding physicians, 67 identified themselves as involved in the treatment of pediatric sarcoma patients. The providers most likely to use any form of deep vein thrombosis prophylaxis were orthopedic surgeons (60{\%}), followed by general surgeons (45{\%}), pediatric oncologists (30{\%}), and medical oncologists (25{\%}). Of the providers polled, 48{\%} use mechanical forms, 20{\%} use chemical forms, and 31{\%} use a combination. CONCLUSIONS: Currently, there is a lack of consensus regarding thromboembolic prophylaxis for pediatric sarcoma patients.",
keywords = "sarcoma, thromboembolic disease, thromboembolic prophylaxis",
author = "Lauren Crocco and Richard Gorlick and Geller, {David S.}",
year = "2013",
month = "1",
doi = "10.1097/MPH.0b013e318266bf72",
language = "English (US)",
volume = "35",
pages = "28--31",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Current practice managements regarding thromboembolic prophylaxis within the pediatric sarcoma patient population

AU - Crocco, Lauren

AU - Gorlick, Richard

AU - Geller, David S.

PY - 2013/1

Y1 - 2013/1

N2 - OBJECTIVE: Children with cancer are approximately 600 times more likely to develop thromboses than the general pediatric population. Current management strategies for children have been extrapolated from adult studies and prophylaxis guidelines remain controversial. The purpose of this study is to survey the current thromboembolic prophylaxis practice methods of physicians treating pediatric sarcoma patients. METHODS: Physicians involved in the care of sarcoma patients were surveyed using a 5-question survey designed to evaluate current clinical practices. RESULTS: Of 107 responding physicians, 67 identified themselves as involved in the treatment of pediatric sarcoma patients. The providers most likely to use any form of deep vein thrombosis prophylaxis were orthopedic surgeons (60%), followed by general surgeons (45%), pediatric oncologists (30%), and medical oncologists (25%). Of the providers polled, 48% use mechanical forms, 20% use chemical forms, and 31% use a combination. CONCLUSIONS: Currently, there is a lack of consensus regarding thromboembolic prophylaxis for pediatric sarcoma patients.

AB - OBJECTIVE: Children with cancer are approximately 600 times more likely to develop thromboses than the general pediatric population. Current management strategies for children have been extrapolated from adult studies and prophylaxis guidelines remain controversial. The purpose of this study is to survey the current thromboembolic prophylaxis practice methods of physicians treating pediatric sarcoma patients. METHODS: Physicians involved in the care of sarcoma patients were surveyed using a 5-question survey designed to evaluate current clinical practices. RESULTS: Of 107 responding physicians, 67 identified themselves as involved in the treatment of pediatric sarcoma patients. The providers most likely to use any form of deep vein thrombosis prophylaxis were orthopedic surgeons (60%), followed by general surgeons (45%), pediatric oncologists (30%), and medical oncologists (25%). Of the providers polled, 48% use mechanical forms, 20% use chemical forms, and 31% use a combination. CONCLUSIONS: Currently, there is a lack of consensus regarding thromboembolic prophylaxis for pediatric sarcoma patients.

KW - sarcoma

KW - thromboembolic disease

KW - thromboembolic prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=84871799007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871799007&partnerID=8YFLogxK

U2 - 10.1097/MPH.0b013e318266bf72

DO - 10.1097/MPH.0b013e318266bf72

M3 - Article

C2 - 22995922

AN - SCOPUS:84871799007

VL - 35

SP - 28

EP - 31

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 1

ER -